Completed NA INTERVENTIONAL 2-arm NCT01591499

Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal (INNOVATION)

Clinical Evaluation of the Biofinity Multifocal Lens Compared With the Air Optix Aqua Multifocal Lens and With PureVision Multifocal Lens (INNOVATION PRESBYOPIA Study)

Sponsor: CooperVision, Inc.

Conditions Presbyopia

Interventions BIOFINITY® MF - AIR OPTIX® AQUA MF BIOFINITY® MF - PUREVISION® MF

Updated 8 times since 2017 Last updated: Jul 28, 2020 Started: Sep 30, 2011 Primary completion: Dec 31, 2011 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01591499, this NA trial focuses on Presbyopia and remains completed. Sponsored by CooperVision, Inc., it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

May 2025 — Present [monthly]

Completed NA
Jan 2025 — May 2025 [monthly]

Completed NA
Sep 2024 — Jan 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 3 earlier versions

Sep 2020 — Jan 2021 [monthly]

Completed NA

Phase: PHASE4 → NA
Jun 2018 — Sep 2020 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CooperVision, Inc.

Data source: CooperVision International Limited (CVIL)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.